CRESCENT BIOPHARMA, INC. — Investor Relations & Filings
Filings indexed
611
across all filing types
Latest filing
2026-02-26
Regulatory Filings
Country
US
United States of America
Listing
US
CBIO
Crescent Biopharma, Inc. is a biopharmaceutical company dedicated to researching and developing the next wave of cancer therapies. The company's vision is to build a world-leading oncology organization by focusing on revolutionary shifts in the field to transform cancer treatment. Its strategy involves advancing a pipeline of therapies with multiple modalities, including precision-engineered small molecule therapeutics, designed to address cancer on various fronts. Crescent Biopharma aims to deliver a new standard of care for people living with cancer through its innovative pipeline.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - CRESCENT BIOPHARMA, INC. (0001253689) (Filer) | 2026-02-26 | English | |
| 10-K - CRESCENT BIOPHARMA, INC. (0001253689) (Filer) | 2026-02-26 | English | |
| SCHEDULE 13G/A Filing | 2026-02-05 | English | |
| 424B3 Filing | 2026-01-15 | English | |
| S-1 Filing | 2026-01-07 | English | |
| FORM 4 | 2025-12-17 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 32889116 | 8-K - CRESCENT BIOPHARMA, INC. (0001253689) (Filer) | 2026-02-26 | English | ||
| 32889117 | 10-K - CRESCENT BIOPHARMA, INC. (0001253689) (Filer) | 2026-02-26 | English | ||
| 28515353 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 28515510 | 424B3 Filing | 2026-01-15 | English | ||
| 28515705 | S-1 Filing | 2026-01-07 | English | ||
|
2025
10 filings
| |||||
| 11606985 | FORM 4 | 2025-12-17 | English | ||
| 11607002 | FORM 4 | 2025-12-17 | English | ||
| 11606986 | FORM 4 | 2025-12-17 | English | ||
| 11606987 | FORM 4 | 2025-12-17 | English | ||
| 11606988 | FORM 4 | 2025-12-17 | English | ||
| 11606989 | FORM 4 | 2025-12-17 | English | ||
| 11606990 | FORM 4 | 2025-12-17 | English | ||
| 11607005 | FORM 4 | 2025-12-17 | English | ||
| 11606991 | S-4 POS | 2025-12-12 | English | ||
| 11606992 | Major Shareholding Notification 2025 | 2025-12-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
CRESCENT BIOPHARMA, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33678/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33678 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33678 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33678 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33678}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CRESCENT BIOPHARMA, INC. (id: 33678)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.